胰岛素、口服降糖药和癌症：观察性研究是提供答案还是制造问题？
摘要
大量的研究（尤其是荟萃分析）结果表明，糖尿病可增加机体罹患癌症的风险。由于目前全球糖尿病患者诊治的海量数据大多可通过电子化登记贮存，因此研究者可利用这些管理性数据库对胰岛素、口服降糖药与癌症的发生风险进行分析。
出处
《中华糖尿病杂志》
CAS
2012年第7期385-388,共4页
CHINESE JOURNAL OF DIABETES MELLITUS
参考文献35
-
1Yang X,So WY,Ma RC. Diabetes and cancer:the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry[J].Diabetes/Metabolism Research and Review,2012.379-387.
-
2Hemkens LG,Grouven U,Bender R. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues:a cohort study[J].Diabetologia,2009.1732-1744.
-
3Jonasson JM,Ljung R,Talback M. Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden[J].Diabetologia,2009.1745-1754.
-
4Colhoun HM,SDRN Epidemiology group. Use of insulin glargine and cancer incidence in Scotland:a study from the Scottish Diabetes Research Network Epidemiology Group[J].Diabetologia,2009.1755-1765.
-
5Currie CJ,Poole CD,Gale EA. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes[J].Diabetologia,2009.1766-1777.
-
6Smith U,Gale EA. Does diabetes therapy influence the risk of cancer[J].Diabetologia,2009.1699-1708.
-
7Lewis JD,Ferrara A,Peng T. Risk of bladder cancer among diabetic patients treated with pioglitazone:interim report of a longitudinal cohort study[J].Diabetes Care,2011.916-922.
-
8U.S. Food and Drug Administration. FDA drug safety communication: update to ongoing safety review of actos (pioglitazone) and increased risk of bladder cancer[EB/OL].http://www.fda.gov/drugs/drugsafety/ucm259150.htm,2012.
-
9Noto H,Goto A,Tsujimoto T. Cancer risk in diabetic patients treated with metformin:a systematic review and metaanalysis[J].PLoS One,2012.e33411.
-
10Johnson JA,Gale EA. Diabetes,insulin use,and cancer risk:are observational studies part of the solution-or part of the problem[J].Diabetes,2010.1129-1131.
-
1包立道,任显华,王毅.内蒙古医科大学附属医院Ⅰ类切口手术预防性应用抗菌药物分析[J].中国医院用药评价与分析,2013,13(1):41-44. 被引量：5
-
2杨咏梅,曲迅,曹玉美.生物信息学在医学研究中的应用进展[J].医学综述,2007,13(22):1681-1683. 被引量：7
-
3周旺.我院2012年1～6月份碳青霉烯类抗菌药物临床应用情况分析[J].临床合理用药杂志,2013,6(14):88-89. 被引量：2
-
4张新江.医院药剂科与药品质量控制[J].交通医学,2003,17(3):239-239.
-
5胡娜.试论大数据时代高校图书馆电子资源特色化服务[J].亚太教育,2016,0(27):196-196. 被引量：1
-
6赵盼.门诊药房管理制度[J].医学美学美容（中旬刊）,2014,23(11):678-678.
-
7任彤,谢悦旭,杨玉玲.浅谈某院药库的管理[J].中国医药指南,2012,10(21):692-693.
-
8范丽珠.60％以上的处方抗组胺药使用者呈“过敏疾病阴性”[J].国外药讯,2004(11):19-19.
-
9李秀银,李明川,王璐.医院门诊药房的管理探讨[J].临床合理用药杂志,2012,5(25):167-168. 被引量：2
-
10王连心,向永洋,谢雁鸣,申浩,艾青华.参麦注射液自发呈报系统的药物警戒研究[J].中国中药杂志,2013,38(18):2987-2993. 被引量：5
